BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 22281151)

  • 21. Lectins from
    ; Ramos EL; Santana SS; Silva MV; Santiago FM; Mineo TW; Mineo JR
    Front Cell Infect Microbiol; 2016; 6():164. PubMed ID: 27933277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-parasitic activity of Annona muricata L. leaf ethanolic extract and its fractions against Toxoplasma gondii in vitro and in vivo.
    Miranda NC; Araujo ECB; Justino AB; Cariaco Y; Mota CM; Costa-Nascimento LA; Espindola FS; Silva NM
    J Ethnopharmacol; 2021 Jun; 273():114019. PubMed ID: 33716084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the mood-stabilizing agent valproic acid as a preventative for toxoplasmosis in mice and activity against tissue cysts in mice.
    Goodwin DG; Strobl J; Mitchell SM; Zajac AM; Lindsay DS
    J Parasitol; 2008 Apr; 94(2):555-7. PubMed ID: 18564764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.
    Mui EJ; Jacobus D; Milhous WK; Schiehser G; Hsu H; Roberts CW; Kirisits MJ; McLeod R
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3463-7. PubMed ID: 16048961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil.
    Alves CF; Vitor RW
    Parasite; 2005 Jun; 12(2):171-7. PubMed ID: 15991831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.
    Portes JA; De Souza W
    Parasitol Res; 2019 Dec; 118(12):3479-3489. PubMed ID: 31728720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
    Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
    Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis and S phase of the cell cycle in BeWo trophoblastic and HeLa cells are differentially modulated by Toxoplasma gondii strain types.
    Angeloni MB; Silva NM; Castro AS; Gomes AO; Silva DA; Mineo JR; Ferro EA
    Placenta; 2009 Sep; 30(9):785-91. PubMed ID: 19643475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buprenorphine does not affect acute murine toxoplasmosis and is recommended as an analgesic in Toxoplasma gondii studies in mice.
    Lindsay DS; Kaur T; Mitchell SM; Goodwin DG; Strobl J; Dubey JP
    J Parasitol; 2005 Dec; 91(6):1488-90. PubMed ID: 16544426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In Vitro and in Vivo Effects of Nitrofurantoin on Experimental Toxoplasmosis.
    Yeo SJ; Jin C; Kim S; Park H
    Korean J Parasitol; 2016 Apr; 54(2):155-61. PubMed ID: 27180573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new type of pterocarpanquinone that affects Toxoplasma gondii tachyzoites in vitro.
    Portes Jde A; Netto CD; da Silva AJ; Costa PR; DaMatta RA; dos Santos TA; De Souza W; Seabra SH
    Vet Parasitol; 2012 May; 186(3-4):261-9. PubMed ID: 22177332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxoplasma gondii: fluconazole and itraconazole activity against toxoplasmosis in a murine model.
    Martins-Duarte ES; Lemgruber L; de Souza W; Vommaro RC
    Exp Parasitol; 2010 Apr; 124(4):466-9. PubMed ID: 20045696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preliminary application of PCR to curative effect assessment of chemotherapy against experimental acute infection of Toxoplasma gondii in mice].
    Xiang X; Ke OY; Zhang Z
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):5-7. PubMed ID: 9868016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New naphthoquinones and an alkaloid with in vitro activity against Toxoplasma gondii RH and EGS strains.
    Ferreira RA; de Oliveira AB; Gualberto SA; Miguel Del Corral JM; Fujiwara RT; Gazzinelli Guimarães PH; de Almeida Vitor RW
    Exp Parasitol; 2012 Dec; 132(4):450-7. PubMed ID: 23000485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of pyrimethamine and sulfadiazine on the fine structure and multiplication of Toxoplasma gondii in cell cultures.
    Sheffield HG; Melton ML
    J Parasitol; 1975 Aug; 61(4):704-12. PubMed ID: 1165554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy in experimental toxoplasmosis: comparison of the efficacy of trimethoprim-sulfur and pyrimethamine-sulfur combinations.
    Seah SK
    J Trop Med Hyg; 1975 Jul; 78(7):150-3. PubMed ID: 1177347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Extracts from Thai Piperaceae Plants against Infection with Toxoplasma gondii.
    Leesombun A; Boonmasawai S; Shimoda N; Nishikawa Y
    PLoS One; 2016; 11(5):e0156116. PubMed ID: 27213575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nifurtimox plus pyrimethamine for treatment of murine toxoplasmosis.
    Aguirre-Cruz L; Velasco O; Sotelo J
    J Parasitol; 1998 Oct; 84(5):1032-3. PubMed ID: 9794648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two 2-hydroxy-3-alkyl-1,4-naphthoquinones with in vitro and in vivo activities against Toxoplasma gondii.
    Khan AA; Nasr M; Araujo FG
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2284-9. PubMed ID: 9736550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulfadiazine Sodium Ameliorates the Metabolomic Perturbation in Mice Infected with Toxoplasma gondii.
    Zhou CX; Gan Y; Elsheikha HM; Chen XQ; Cong H; Liu Q; Zhu XQ
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.